News

Morningstar1d
IOVA SECURITIES NOTICE: Did Iovance Biotherapeutics, Inc. Commit Securities Fraud? Contact BFA Law about the Class Action Lawsuit by July 14
NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and ...
Morningstar11d
IOVA Shareholder Alert: Robbins LLP Informs Investors of the Iovance Biotherapeutics, Inc. Class Action Lawsuit
To be notified if a class action against Iovance Biotherapeutics, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
manilatimes7d
Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes
LONDON, Ontario and BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell ...
TMCnet9d
Law Offices of Frank R. Cruz Encourages Iovance Biotherapeutics, Inc. (IOVA) Investors To Inquire About Securities Fraud Class Action
IF YOU SUFFERED A LOSS ON YOUR IOVANCE BIOTHERAPEUTICS, INC. INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT.
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit ...
Business Wire12d
Law Offices of Howard G. Smith Encourages Iovance Biotherapeutics, Inc. (IOVA) Investors to Inquire About Securities Fraud Class Action
Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) securities between ...
Stockhouse5d
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May ...
Stockhouse8d
IOVA NOTIFICATION: A Class Action Has Been Filed on Behalf of Iovance Biotherapeutics, Inc. Investors - Contact BFA Law by July 14 Legal Deadline
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) ...
FORE Biotherapeutics Raises $38 Million in Series D-2 Financing for the Continued Advancement of Plixorafenib
FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced a $38 million Series D-2 financing. For ...
WRBL9d
Recover Investment Losses: Levi & Korsinsky Files Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
THE LAWSUIT: A class action securities lawsuit was filed against Iovance Biotherapeutics, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud ...
Business Wire8d
IOVA BREAKING NEWS: Iovance Biotherapeutics, Inc. Stock Plummets 44% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NASDAQ:IOVA)
NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the ...